tiprankstipranks
RenovoRx (RNXT)
NASDAQ:RNXT
US Market

RenovoRx (RNXT) Financial Statements

Compare
71 Followers

RenovoRx Financial Overview

RenovoRx's market cap is currently $36.63M. The company's EPS TTM is $-0.572; its P/E ratio is ―; RenovoRx is scheduled to report earnings on May 19, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -6.00K$ -9.00K$ 0.00$ 0.00
Operating Income$ -11.40M$ -9.95M$ -5.67M$ -3.20M$ -3.90M
EBITDA$ -11.39M$ -9.94M$ -5.66M$ 0.00$ 0.00
Net Income$ -10.23M$ -9.77M$ -7.10M$ -4.38M$ -3.78M
Balance Sheet
Cash & Short-Term Investments$ 1.17M$ 6.44M$ 15.19M$ 1.79M$ 2.10M
Total Assets$ 1.47M$ 7.26M$ 16.29M$ 1.91M$ 2.27M
Total Debt$ 0.00$ 0.00$ 0.00$ 2.79M$ 12.39M
Net Debt$ -1.17M$ -6.44M$ -15.19M$ 995.00K$ 10.29M
Total Liabilities$ 4.47M$ 1.10M$ 938.00K$ 16.57M$ 13.20M
Stockholders' Equity$ -3.00M$ 6.16M$ 15.35M$ -14.66M$ -10.93M
Cash Flow
Free Cash Flow$ -10.26M$ -8.81M$ -5.93M$ -3.53M$ -3.35M
Operating Cash Flow$ -10.26M$ -8.81M$ -5.92M$ -3.53M$ -3.35M
Investing Cash Flow$ 2.03M$ -2.03M$ -15.00K$ 0.00$ -1.00K
Financing Cash Flow$ 5.01M$ 42.00K$ 19.33M$ 3.20M$ 0.00
Currency in USD

RenovoRx Earnings and Revenue History

RenovoRx Debt to Assets

RenovoRx Cash Flow

RenovoRx Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis